Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Anticancer compounds from Boehringer Ingelheim acting on kinases

Jan. 17, 2001

Exclusive rights to NX-211 obtained by Gilead from GSK

Jan. 17, 2001

IntraBiotics completes patient enrollment in phase III Protegrin IB-367 Rinse study

Jan. 17, 2001

Update on Active Biotech's TTS products under clinical development

Jan. 17, 2001

Telik and the University of Arizona enter TRAP alliance

Jan. 17, 2001

Genome-derived candidate for oncology identified as part of Millennium/Bayer alliance

Jan. 17, 2001

Xcytrin clinical development program update

Jan. 16, 2001

New antitumor prodrugs activated by FAPalpha

Jan. 15, 2001

Inhibitors of growth factor receptor tyrosine kinases developed at BMS

Jan. 15, 2001

Sonus begins phase I evaluation of less toxic form of paclitaxel

Jan. 15, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 27, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...